Literature DB >> 4812097

Ocular complications in the Weill-Marchesani syndrome.

A D Jensen, H E Cross, D Paton.   

Abstract

Entities:  

Mesh：

Year:  1974        PMID： 4812097     DOI： 10.1016/0002-9394(74)90685-0

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  11 in total

1.  Visual outcome and incidence of glaucoma in patients with microspherophakia.

Authors:  R Muralidhar; K Ankush; P Vijayalakshmi; V P George
Journal:  Eye (Lond)       Date:  2014-11-14       Impact factor: 3.775

Review 2.  Lens-induced glaucoma.

Authors:  J P Ellant; S A Obstbaum
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

3.  The eye as a window to a rare disease: ectopia lentis and homocystinuria, a Pakistani perspective.

Authors:  Maeirah Shafique; Waqar Muzaffar; Mazhar Ishaq
Journal:  Int Ophthalmol       Date:  2015-05-17       Impact factor: 2.031

4.  Factors Related to Visual Outcomes after Lens Surgery in Isolated Microspherophakia.

Authors:  Jialei Zheng; Lina Cheng; Zexu Chen; Tianhui Chen; Yongxiang Jiang
Journal:  J Ophthalmol       Date:  2022-06-15       Impact factor: 1.974

5.  Histology of the lens in the Weill-Marchesani syndrome.

Authors:  H Fujiwara; Y Takigawa; S Ueno; K Okuda
Journal:  Br J Ophthalmol       Date:  1990-10       Impact factor: 4.638

6.  Angle closure in younger patients.

Authors:  Brian M Chang; Jeffrey M Liebmann; Robert Ritch
Journal:  Trans Am Ophthalmol Soc       Date:  2002

Review 7.  Cionni endocapsular ring implantation in Marfan's Syndrome.

Authors:  Irit Bahar; Igor Kaiserman; David Rootman
Journal:  Br J Ophthalmol       Date:  2007-11       Impact factor: 4.638

8.  Progressive myopia in early onset chronic angle closure glaucoma.

Authors:  M Cherny; A M Brooks; W E Gillies
Journal:  Br J Ophthalmol       Date:  1992-12       Impact factor: 4.638

9.  Identification and molecular characterisation of a homozygous missense mutation in the ADAMTS10 gene in a patient with Weill-Marchesani syndrome.

Authors:  Hannes Steinkellner; Julia Etzler; Laura Gogoll; Jürgen Neesen; Eva Stifter; Oliver Brandau; Franco Laccone
Journal:  Eur J Hum Genet       Date:  2014-12-03       Impact factor: 4.246

10.  Tumour necrosis factor alpha, lipid peroxidation and NO* are increased and associated with decreased free-radical scavenging enzymes in patients with Weill-Marchesani syndrome.

Authors:  Cem Evereklioglu; Yusuf Turkoz; Mustafa Calis; Fuat Duygulu; Aysun B Karabulut
Journal:  Mediators Inflamm       Date:  2004-06       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.